Prot #PALV-02: A Multicenter, Four-Part, Phase 2/3 Study Evaluating the Safety and Efficacy of PTX-022 in the Treatment of Adults with Moderate to Severe Pachyonychia Congenita

Project: Research project

Project Details

StatusActive
Effective start/end date7/10/197/10/22

Funding

  • Palvella Therapeutics, Inc. (Prot #PALV-02)